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Damage to skin DNA by solar UV is largely unavoidable, and an optimal cellular response to it requires the
coordinated operation of proteins in numerous pathways. A fully functional DNA repair proteome for removing
harmful DNA lesions is a prerequisite for an appropriate DNA damage response. Genetically determined failure
to repair UV–induced DNA damage is associated with skin photosensitivity and increased skin cancer risk.
Patients treated with immunosuppressant/anti-inflammatory thiopurines are also photosensitive and have high
rates of sun-related skin cancer. Their DNA contains the base analog 6-thioguanine (6-TG), which acts as a UVA
photosensitizer to generate reactive oxygen species (ROS), predominantly singlet oxygen (1O2). ROS damage
both DNA and proteins. Here we show that UVA irradiation of cultured human cells containing DNA 6-TG causes
significant protein oxidation and damages components of the DNA repair proteome, including the Ku, OGG-1,
MYH, and RPA proteins. Assays of DNA repair in intact cells or in cell extracts indicate that this protein damage
compromises DNA break rejoining and base and nucleotide excision repair. As these experimental conditions
simulate those in the skin of patients taking thiopurines, our findings suggest a mechanism whereby UVA in
sunlight may contribute to skin carcinogenesis in immunosuppressed patients.
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INTRODUCTION
Solar UV radiation is a major source of DNA damage. It
comprisesX95% UVA (wavelength 315–400 nm) and around
5% UVB (280–315 nm). Both UVB and UVA are considered
carcinogenic to humans (Ghissassi et al., 2009). The
absorption of UVB photons by DNA nucleobases creates
potentially mutagenic cyclobutane pyrimidine dimers (CPDs)
and 6,4 pyrimidine-pyrimidone photoproducts (6,4 Py:Pys).
Persistent UV–induced DNA lesions, particularly CPDs, are
implicated in skin cancer development, and impaired removal
of these lesions in xeroderma pigmentosum (XP) individuals is
associated with photosensitivity and high skin cancer rates. In
general, sunlight-related skin cancers contain characteristic
mutations at dipyrimidine sites that are consistent with a
causative role for unrepaired pyrimidine dimers in carcino-
genesis (Queille et al., 2007; Pleasance et al., 2010).
UVA also damages cellular DNA. It generates reactive
oxygen species (ROS), predominantly singlet oxygen (1O2).
Until recently, oxidative DNA lesions, principally DNA 8-
oxoguanine (8-oxoG), were regarded as the most important
UVA–induced DNA lesions. It is now recognized that CPDs
comprise a significant fraction of UVA–induced DNA damage
(Douki et al., 2003; Tewari et al., 2012). In comparison with
UVB, UVA induces CPDs less efficiently (Cadet et al., 2005)
and by a different mechanism (Mouret et al., 2010).
Although DNA has long been considered their most
important target (Cadet et al., 2005), ROS also damage
proteins and 1O2 is particularly effective in this regard
(Davies, 2003). Protection against cancer requires
appropriate DNA damage responses that involve the efficient
coordinated actions of numerous proteins. The enzymes
required to remove DNA lesions—the DNA repair
proteome—are a key part of this DNA damage response.
Several distinct DNA repair pathways carry out the removal of
different DNA lesions. Among these, nonhomologous end-
joining (NHEJ) repairs DNA double-strand breaks (DSBs) and
NHEJ–deficient Lig4 syndrome patients are radio- and photo-
sensitive (O’Driscoll et al., 2001). Base excision repair (BER)
removes damaged bases with subtle modifications, including
oxidation, and nucleotide excision repair (NER) excises more
bulky DNA lesions including 6,4 Py:Pys and CPDs.
Inactivating mutations in genes encoding NER proteins are
responsible for XP. To avoid mutation fixation by replication
of DNA lesions, the DNA repair proteome must be maximally
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effective. Its effectiveness is threatened under conditions of
oxidative stress in which excessive ROS may cause damage to
participating proteins and to DNA. Even partial inactivation of
DNA repair enzymes may have harmful consequences. The
potential importance of protecting DNA repair proteins is
exemplified by the strong inverse correlation between
radiation resistance and protein oxidation among bacterial
species with widely different radiation sensitivities (Daly,
2009; Krisko and Radman, 2010). In certain highly radia-
tion-resistant organisms, sophisticated antioxidant defenses
that prevent protein damage (Daly, 2009; Krisko et al.,
2011; Slade and Radman, 2011) are associated with
remarkable feats of DNA repair (Zahradka et al., 2006). This
suggests that maintaining a fully active complement of DNA
repair enzymes during oxidative stress conditions may
contribute significantly to preventing the harmful conse-
quences of DNA damage. However, direct evidence for this
is lacking, and the extent to which the human DNA repair
proteome is susceptible to inactivation by oxidation is also
unknown.
Cutaneous UVA photosensitivity is a frequent side effect of
drug treatment (Drucker and Rosen, 2011) and is associated
with drugs as structurally diverse as tetracycline, the
fluoroquinolone antibiotics (Lhiaubet-Vallet et al., 2009) and
the BRAF inhibitor vemurafenib (Dummer et al., 2012; Gelot
et al., 2013). One established example of UVA photosen-
sitization is provided by the selective UVA sensitivity of
patients taking the immunosuppressant azathioprine. In these
patients, photosensitivity is related to the presence of the base
analog 6-thioguanine (6-TG) in their DNA (Warren et al.,
1995; Perrett et al., 2008; Hofbauer et al., 2011). DNA 6-TG is
a UVA chromophore and generates ROS, predominantly 1O2,
when activated by low doses of UVA (Zhang et al., 2007). In
this regard, it acts as a dose modifier for UVA and enhances
the UVA–mediated induction of intracellular 1O2. In view of
the particular susceptibility of proteins to damage by 1O2
(Davies, 2003) and the high incidence of skin cancer
associated with azathioprine treatment in organ transplant
recipients (Euvrard et al., 2003) and in patients treated for
inflammatory conditions (Peyrin-Biroulet et al., 2011; Setshedi
et al., 2012; Ramiscal and Brewer, 2013), we have
investigated how the combination of UVA and DNA 6-TG
harms human cells. We have previously identified several
forms of oxidation-induced DNA damage inflicted by 6-TG/
UVA (reviewed in Brem and Karran, 2012). Here we present
evidence that the human DNA repair proteome is also
damaged by oxidation. By using cultured cells containing
DNA 6-TG and exposed to UVA we identify changes in
essential DNA repair proteins. These changes are associated
with partial inactivation of several DNA repair pathways. Our
findings suggest a mechanism by which solar radiation
contributes to iatrogenic skin cancer.
RESULTS
Protein carbonylation, Ku oxidation, and NHEJ inhibition
Protein carbonylation is a marker of oxidation. To examine
the effects of ROS on DNA-processing proteins, we investi-
gated protein carbonyl formation in nuclear proteins extracted
from cells treated with 6-TG and UVA. To minimize non-
UVA–related toxicity we used CCRF-CEM leukemic cells for
these experiments. CCRF-CEM cells have a defective DNA
mismatch repair system (Taverna et al., 2000) that permits the
accumulation of high levels of DNA 6-TG without toxicity
(Karran and Attard, 2008). This, in turn, facilitates
amplification of the synergy between DNA 6-TG and UVA.
Cells were grown in the presence of 6-TG to allow
replacement of up to 1% of DNA guanine (Brem et al.,
2010) and exposed to low UVA doses. Nuclear protein
carbonyls were selectively derivatized with Alexa Fluor 647
fluorescent hydroxylamine (Poon et al., 2007). PAGE analysis
(Figure 1a) revealed a 6-TG and UVA–dependent increase in
this form of protein oxidation. A preliminary screen by 2D gel
electrophoresis and mass spectrometry reproducibly identified
Ku70, the 70 kDa subunit of the DNA end-binding Ku70:Ku80
(Ku) dimer, as an oxidation target. Western blotting revealed
that a fraction of Ku70 from 6-TG/UVA–treated cells migrated
as a series of partially resolved forms with an approximate
mass of 150 kDa (Figure 1b). The formation of these com-
plexes required treatment with both 6-TG and UVA. Probing
the western blots with anti-Ku80 antibody revealed an appa-
rently identical pattern of high-molecular-weight immuno-
reactive proteins (Figure 1b). Thus, a fraction of both Ku70
and Ku80 in treated cells was in a high-molecular-weight
form. The close resemblance between the 150 kDa species
revealed by both Ku70 and Ku80 antibodies indicates that
these complexes were most likely formed by crosslinking
between the two Ku subunits. The presence of more than one
band suggests incomplete unfolding, possibly related to cross-
linking within the complex.
Ku is a DNA end–binding complex that directs an early step
in NHEJ of DNA DSBs (Jackson, 2002)—the preferred DSB
rejoining pathway in G1-phase cells. NHEJ in vivo can be
monitored by single-cell gel electrophoresis (neutral comet
assay) and quantified as comet tail moment. 6-TG/UVA
treatment inhibited NHEJ. Synchronized G1/early S-phase
HeLa cells (Supplementary Figure S1 online) rejoined most
of the DSBs introduced by 15 Gy ionizing radiation (IR) within
4 hours. (HeLa cells were used in these experiments because
attempts to synchronize CCRF-CEM cells yielded insufficient
synchrony.) Treatment with 6-TG induced a low level of DNA
double-strand breakage in HeLa cells, and UVA irradiation
caused a further increase in DSBs (Figure 1c). Repair of the
DSBs induced by 6-TG and UVA treatment was inefficient and
no significant rejoining was observed in cells treated with 1mM
6-TG and UVA (Figure 1c). Although IR and 6-TG/UVA may
introduce different types of DSBs, the failure of HeLa cells to
rejoin the DSBs induced by 6-TG/UVA is compatible with an
attenuated NHEJ pathway. Ku-defective cells (Taccioli et al.,
1994) did not rejoin IR–induced DSBs, confirming that the
assay addressed Ku-dependent NHEJ.
Oligonucleotide band-shift assays showed that 6-TG/UVA
treatment impaired Ku binding to DNA ends. Extracts from 6-
TG/UVA–treated cells bound significantly less oligonucleotide
than did extracts from cells treated with either 6-TG or UVA
alone (Figure 1d). Inclusion of an anti-Ku antibody generated a
slowly migrating supershifted complex confirming that the
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observed binding was Ku-mediated (Figure 1d). Assays of end
ligation of linearized plasmids by cell extracts provided
unequivocal evidence that NHEJ was compromised by 6-
TG/UVA treatment. Figure 1e shows that extracts from
untreated cells or from cells treated with 6-TG or with UVA
alone generated trimer and longer ligation products. Extracts
from 6-TG/UVA–treated cells produced fewer dimer
molecules, and trimer and longer forms were not observed.
Ku was the limiting factor in these in vitro assays and
NHEJ activity was fully restored when the extracts were
supplemented with purified recombinant Ku (Figure 1f). Taken
together, the observations indicate that 6-TG/UVA treat-
ment inactivates Ku to a degree sufficient to reduce NHEJ
capability.
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Figure 1. Ku oxidation and nonhomologous end-joining (NHEJ). (a) Protein carbonylation: Extracts were prepared from CCRF-CEM cells treated with 6-TG for
24 hours and irradiated with UVA (20 kJ m 2) as shown. Protein carbonyls were derivatized with Alexa Fluor 647 fluorescent hydroxylamine (Poon et al., 2007).
Proteins (10mg) were separated by PAGE and carbonyls were visualized by 633 nm fluorescence. (b) Ku crosslinking: Extracts (10mg) prepared from CCRF-CEM
cells grown for 24 hours at the concentrations of 6-TG shown and irradiated with UVA (10 kJ m2) or unirradiated (as indicated) were analyzed by western
blotting. Probes were monoclonal antibodies against Ku70 (left) or Ku80 (right). The arrows indicate the positions of the 150 kDa protein marker, Ku70 and Ku80.
(c) Double-strand break (DSB) rejoining: HeLa or Chinese hamster xrs6 cells were synchronized by double thymidine block. HeLa cells were allowed to
incorporate 6-TG between thymidine treatments by growth in medium containing 6-TG as shown. G1/S-phase synchronized cells were irradiated either with
ionizing radiation (IR) or with UVA at the indicated doses. DSBs were analyzed by neutral comet assay in cells sampled at the times indicated after either UVA or
IR. The thymidine block was maintained throughout. Each dot represents a single comet measurement. Bars indicate the median tail moment of X50 comets.
(d) DNA end-binding: CCRF-CEM cells grown in the absence or presence of 0.6mM 6-TG were irradiated with 20 kJ m2 UVA. Cell extracts were incubated with
an end-labeled duplex 30-mer oligonucleotide. Products were separated by electrophoresis through non-denaturing polyacrylamide gels. The sample on the far
right was post-incubated with a polyclonal Ku antibody before electrophoresis. (e) NHEJ: End ligation of linearized plasmid (5.2 kbp) was assayed in extracts
prepared from CCRF-CEM cells that had been treated with 6-TG (0.1mM) and irradiated with 20 kJ m2 UVA as indicated. The positions of ligated dimer, trimer,
and tetramer molecules are shown. (f) NHEJ complementation: NHEJ was assayed in extracts from CCRF-CEM cells treated with 6-TG and UVA as in e or left
untreated. The rejoining reaction in the far right lane was supplemented with 2 103 U of purified recombinant Ku (Trevigen).
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Protein thiol oxidation, OGG-1 and MYH inhibition, and
attenuated base excision repair
Thiols are another potentially important oxidation target. To
examine the effects of 6-TG/UVA on protein thiols, CCRF-CEM
nuclear extracts were reacted with N-ethylmaleimide to block
all reduced sulfhydryls. Disulfide bonds were then reduced
and derivatized with Alexa Fluor 647 fluorescent maleimide
(Baty et al., 2002). Treated extracts were separated by PAGE
and proteins detected by SyproRuby staining. Those containing
derivatized oxidized sulfhydryl groups were visualized by their
green fluorescence. Figure 2a shows that 6-TG/UVA treatment
markedly increased thiol oxidation of nuclear proteins.
The OGG-1 DNA glycosylase initiates base excision repair
(BER) of the mutagenic DNA oxidation product 8-oxoG. It
contains eight cysteine residues and their oxidation state
significantly influences the activity of OGG-1 in vitro
(Bravard et al., 2006). 6-TG/UVA treatment is a source of
DNA 8-oxoG (Cooke et al., 2008). We compared the rates of
disappearance of DNA 8-oxoG induced by 6-TG/UVA with
those induced by KBrO3—a chemical that introduces DNA 8-
oxoG largely independently of ROS (Kawanishi and Murata,
2006). ELISA assays revealed no detectable decrease in the
level of DNA 8-oxoG 30 minutes after UVA irradiation of
6-TG-treated cells (Figure 2b). In contrast, DNA 8-oxoG
induced by KBrO3 treatment was removed with a half-time
of around 10–15 minutes and background levels were reached
within 30 minutes of drug removal. These observations are
consistent with inhibition of OGG-1-mediated BER by the
burst of ROS produced by DNA 6-TG photoactivation.
The removal of 8-oxoG from DNA by OGG-1 occurs in a
single step and requires no protein cofactors. The apurinic site
generated by OGG-1 is then a substrate for cleavage by
apurinic endonucleases. The possibility that OGG-1 was
inactivated in cells treated with 6-TG/UVA was investigated
by assaying the ability of nuclear extracts to generate a
radiolabeled 13-nucleotide product from a 50-end radiola-
beled duplex 23-mer oligonucleotide containing a single 8-
oxoG. Although the extracts contain apurinic endonucleases,
they were supplemented with recombinant Escherichia coli
endonuclease IV to ensure quantitative cleavage of the OGG-
1 depurinated oligonucleotide. Figure 2c shows that nuclear
extracts of 6-TG/UVA–treated CCRF-CEM cells contained
significantly less OGG-1 activity than did the extracts from
untreated cells or from cells treated with 6-TG or UVA alone.
The MYH DNA glycosylase is also involved in DNA 8-
oxoG processing (Russo et al., 2007). MYH acts at replication
to avert G 4 T transversion mutations by removing the
adenine bases inappropriately incorporated opposite
templating 8-oxoG lesions. MYH contains 12 cysteines, 4 of
which coordinate a conserved [4Fe-4S] cluster domain
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Figure 2. Protein thiol, OGG-1, and MYH oxidation. (a) Protein thiol oxidation (Baty et al., 2002): Nuclear extracts from untreated ( ) or 6-TG (0.6mM)/UVA
(20 kJ m2)–treated (þ ) CCRF-CEM cells were incubated with N-ethylmaleimide to block reduced thiol groups. Extracts were then treated with dithiothreitol (DTT)
and newly reduced thiols were derivatized with Alexa Fluor 647 fluorescent maleimide. Proteins (10mg) were separated by PAGE. Total proteins were stained with
Sypro Ruby (red) and derivatized thiols were visualized by 633 nm fluorescence. (b) DNA 8-oxoguanine (8-oxoG) removal in vivo: CCRF-CEM cells were grown
for 48 hours in 0.6mM 6-TG and irradiated with 50 kJ m2 UVA. DNA was extracted at the times shown and DNA 8-oxodG was measured by ELISA. Control cells
received either UVA alone or 40 mM KBrO3 for 15 minutes. Values are expressed as 8-oxodG per 10
6 dG residues. A background equivalent to 7 oxoG per 106 dG
has been subtracted. (c) OGG-1 activity: CCRF-CEM cells were grown for 48 hours at the concentrations of 6-TG shown and irradiated with 20 kJ m 2 UVA as
indicated. Nuclear extracts were incubated with a 50-end labeled duplex 23-mer oligonucleotide with a single 8 oxoG:C base pair 13 nt from the 50 end in the
presence of E. coli endonuclease IV (Endo(IV)). The cleavage product (13-mer) was resolved by denaturing PAGE. (d) MYH activity: MYH activity in the same
CCRF-CEM nuclear extracts was assayed using a 23-mer duplex oligonucleotide substrate that placed a single A:8-oxoG base pair nine nucleotides from the
50 labeled end of the A-containing strand. M, 9-mer marker; nt, nucleotide.
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(Luncsford et al., 2010). This relatively high cysteine content
makes MYH a likely oxidation target. Similar to OGG-1, MYH
is also monomeric and acts without cofactor proteins. MYH
activity was assayed by examining cleavage of the
A-containing strand of a duplex oligonucleotide containing a
single A:8-oxoG base pair. Figure 2d shows that extracts from
6-TG/UVA–treated CCRF-CEM cells contained less MYH
activity than did extracts from untreated cells or from cells
treated with either 6-TG or UVA alone. Thus, the two DNA
glycosylases required for efficient processing of DNA 8-oxoG
are measurably inactivated by 6-TG/UVA treatment. The
findings of significantly impaired OGG-1 and MYH activity
are consistent with reduced BER activity and the observed
persistence of DNA 8-oxoG in 6-TG/UVA–treated cells.
The combination of 6-TG and UVA is cytotoxic (O’Donovan
et al., 2005). To examine whether reduced BER is simply a
consequence of this toxicity and affected all pathways, we
investigated the effects of 6-TG/UVA on the repair of DNA
uracil. The noncanonical DNA base uracil is occasionally
misincorporated into DNA during replication. Its removal by
BER is initiated by the uracil-DNA glycosylase (UNG) DNA
glycosylase (Nilsen et al., 2000). This BER pathway is
inoperative in ung / mouse embryonic fibroblasts (MEFs)
and they accumulate DNA uracil to a measurable extent. The
presence of DNA uracil is revealed by the single-cell
electrophoresis (comet) assay as an increase in comet tail
moment following digestion of DNA samples with purified
UNG before electrophoresis under alkaline conditions (Nilsen
et al., 2000). To examine whether uracil BER was affected by
6-TG/UVA treatment, we analyzed DNA from ung / and
WT (ungþ /þ ) MEFs (Figure 3a). As expected, UNG digestion
of samples from ung / MEFs increased the comet tail
moment, indicating that these cells retain a significant
steady-state level of DNA uracil. UNG digestion increased
the comet tail moment to a similar extent in cells that had been
treated with 6-TG or UVA, indicating that neither treatment
affected the incorporation of uracil. Combined 6-TG/UVA
treatment caused a reduction in the tail moment. This behavior
is consistent with the formation of interstrand DNA crosslinks
(Brem et al., 2011). UNG digestion also increased the comet
tail moment from cells treated with 6-TG/UVA, indicating that
DNA uracil continued to accumulate after treatment. In
contrast, uracil was not detected in the DNA of ungþ /þ
MEFs. UNG digestion did not increase the tail moment from
cells treated with 6-TG and UVA either alone or in
combination (Figure 3a). The most likely explanation for these
findings is that BER of incorporated uracil continues to operate
effectively after 6-TG/UVA treatment.
In vitro assays confirmed that 6-TG/UVA–treated cells retain
functional uracil BER and that the activity of UNG, the initial
and rate-limiting step for uracil BER, was not diminished by 6-
TG/UVA treatment. Figure 3b shows that nuclear extracts
prepared from 6-TG-treated CCRF-CEM cells contain compar-
able levels of UNG activity before and after UVA irradiation.
The retention of full UNG activity after 6-TG/UVA treatment
was confirmed in HeLa cells. Extracts from HeLa cells in
which the activity of OGG-1 was significantly impaired by 6-
TG/UVA treatment contained undiminished UNG activity
(Supplementary Figure S2 online). These findings indicate that
reduced DNA repair activity after 6-TG/UVA treatment is not
simply a reflection of 6-TG/UVA cytotoxicity and at least one
other BER pathway is unimpaired.
Inhibition of NER
UVA irradiation of cultured cells treated with 6-TG mimics
and amplifies events in the skin of patients taking the
immunosuppressant thiopurines azathioprine or 6-mercapto-
purine whose DNA contains 6-TG (Perrett et al., 2008). These
patients are UVA photosensitive and have high rates of sun-
related skin cancer (Euvrard et al., 2003). To examine the
effects of 6-TG/UVA on NER, the major defense against skin
cancer, CCRF-CEM cells containing DNA 6-TG were
irradiated with both UVA and UVC, and photoproduct
persistence was analyzed by ELISA. Figure 4 shows that
6-TG/UVA treatment almost completely inhibited the efficient
NER of 6,4 Py:Pys that occurred in untreated cells or in cells
exposed to either 6-TG or UVA alone. The inhibitory effect of
6-TG/UVA on NER was not confined to CCRF-CEM cells, and
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Figure 3. DNA uracil excision. (a) DNA uracil determination in vivo: ung /
and ungþ /þ MEFs were allowed to incorporate 6-thioguanine (6-TG) (0.15mM,
48 hours) and UVA–irradiated (20 kJ m2) as indicated. The presence of DNA
uracil was analyzed by the alkaline comet assay after digestion with UNG as
indicated. Bars indicate the median tail moment of X100 comets. (b) Uracil
excision in vitro: Nuclear extracts of CCRF-CEM cells that had been treated
with 6-TG and UVA (20kJ m2) as indicated were incubated with end-labeled
duplex oligonucleotides containing a single uracil 13 nucleotide (nt) from the
50 end of the labeled strand. Products were separated by denaturing PAGE.
Control samples (lane 2 from left) were incubated with purified recombinant
UNG2 DNA glycosylase and E. coli endonuclease IV (Endo(IV)). UNG, uracil-
DNA glycosylase.
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a similar inhibition was observed in HaCaT keratinocytes and
MRC5VA fibroblasts (Supplementary Figure S3 online).
Because the combination of 6-TG and UVA introduces
many different DNA lesions and is cytotoxic, we considered
the possibility that the NER inhibition was simply a reflection
of excess DNA damage or of imminent cell death. To address
this possibility, the efficiency of 6,4 Py:Py NER was deter-
mined in MRC5VA cells exposed to highly cytotoxic treat-
ments, all of which damage DNA. The NER of UVC–induced
6,4 Py:Pys was unaffected by earlier treatment with a toxic
concentration of H2O2 (Supplementary Figure S4A online).
Exposure to lethal doses of IR (5 or 10 Gy) or a 60-minute
treatment with the topoisomerase inhibitors etoposide or
camptothecin (20mM) before UVC irradiation was also without
detectable effect on NER (Supplementary Figure S4B and C
online). All these treatments are highly cytotoxic (o1%
survival after H2O2 (Daehn and Karran, 2008); approxi-
mately 10% and 0.1% survival, respectively, at 5 and 10 Gy;
o1% for the topoisomerase poisons; Hennequin et al., 1994).
The UVC (20 J m2) dose that we used to introduce the DNA
photoproducts is itself highly toxic and causes X90% cell
death. We conclude that the abrogation of NER cannot be
explained simply by the toxicity of 6-TG/UVA treatment.
Reduced activity of NER is not simply a property of cells
that are destined to die and instead reflects damage, most
probably to DNA and/or proteins, induced by 6-TG/UVA.
The possible contribution of protein damage to the inhibi-
tion of NER was addressed by in vitro assays. In the standard
NER assay (Laine et al., 2006), cell extracts are incubated with
a circular duplex DNA containing a site-specific intrastrand
cisplatin crosslink. The approximately 26-nucleotide NER
excision product is detected following its selective
radiolabeling by Sequenase and [a-32P]dCTP (Supplementary
Figure S5 online). HeLa cells were used for these assays
because the preparation of fully proficient NER extracts from
these cells is routine. Figure 5a shows that extracts from
untreated HeLa cells generated the expected family of 27–31
nucleotide excision products. 6-TG/UVA treatment abolished
NER. At high concentrations, 6-TG alone was also somewhat
inhibitory, although its effect was reproducibly exacerbated
when combined with UVA.
Events during the incision steps of NER can be interrogated
in a reconstituted system comprising six purified recombinant
NER factors (the XPA, XPC-HR23B, XPF-ERCC1, and XPG
proteins, together with TFIIH and RPA) (Laine et al., 2006).
Omission of any single component abolishes NER. This system
was used to examine the nature of the NER defect in extracts
prepared from 6-TG/UVA–treated HeLa cells. We assayed the
ability of the HeLa extracts to restore NER activity to a depleted
reconstituted system. Figure 5b (left panel) shows that the HeLa
extract re-established NER in assays from which XPA, XPC-
HR23B, XPF-ERCC1, XPG, or TFIIH was omitted, indicating
that these NER factors were active in the extracts. The HeLa
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Figure 4. Nucleotide excision repair in vivo. CCRF-CEM cells that had been
grown for 24 hours in the presence of 0.3mM 6-thioguanine (6-TG) were
irradiated with 20 J m 2 UVC, followed immediately with 20 kJ m 2 UVA.
DNA was extracted at the times shown and UVC–induced 6:4 Py:Py
photolesions were measured by ELISA. Each point is a mean of triplicate values
that agreed to within 20%. No 6-TG no UVA (K), 6-TGþUVA (’), 6-TG (m),
and UVA (B).
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Figure 5. Nucleotide excision repair in vitro. (a) Nucleotide excision repair
(NER) by HeLa cell extracts: Nuclear extracts from HeLa cells that had been
treated with 6-thioguanine (6-TG) and UVA as indicated were incubated with
a double-stranded circular substrate containing a single 1,3-intrastrand
d(GpTpG)-cisplatin crosslink. The excised oligonucleotides were end-labeled
with Sequenase and resolved on 16% denaturing acrylamide gels.
(b) Complementation (left panel): Complementation of reconstituted NER assay
by HeLa nuclear proteins. The reconstituted NER system comprises XPA, XPC-
HR23B, XPF-ERCC1, XPG, RPA, and TFIIH. Reactions in which nuclear extracts
from 6-TG/UVA (1mM/50 kJm2)–treated HeLa cells (as in a) replaced one of
the purified NER components were performed as indicated. The excised
oligonucleotides were end-labeled with Sequenase and resolved on denaturing
acrylamide gels. (Right panel) Complementation of HeLa nuclear extracts by
addition of purified RPA or XPC-HR23B. Nuclear extracts from 6-TG/UVA
(1mM/50 kJm2)–treated HeLa cells were supplemented with purified RPA,
XPC-HR23B, or both as indicated. The products were analyzed as described
above. nt, nucleotide.
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extracts could not fully complement assays that lacked RPA,
however, indicating that RPA activity was impaired. The
addition of purified RPA restored NER to the inactive HeLa
extracts (Figure 5b, right panel), confirming that RPA activity is
indeed diminished in 6-TG/UVA–treated cells. These findings
identify RPA as a target for inactivation in 6-TG/UVA–treated
cells and show that the extent of this inactivation is sufficient to
reduce the efficiency of NER.
DISCUSSION
Although DNA is an acknowledged oxidation target, proteins
also sustain damage under conditions of oxidative stress. Our
findings reveal that the antioxidant defenses of human cells
are insufficient to prevent widespread protein carbonylation
and thiol oxidation following photoactivation of DNA 6-TG.
Ku, OGG-1, MYH, and RPA, members of the DNA repair
proteome and known (or likely on structural grounds) oxida-
tion targets (Hill and Evans, 2006; Men et al., 2007; Bennett
et al., 2009), are inactivated following oxidative stress induced
by UVA irradiation of cells containing DNA 6-TG. Their
partial inactivation compromises the DSB rejoining (Ku), BER
(OGG-1, MYH), and NER pathways (RPA), thereby creating
conditions that lead to the extended persistence of DNA
lesions. In the particular case of Ku, we were able to
identify an altered form that results from crosslinking
between the Ku70 and Ku80 subunits. We note that Ku
oxidation was originally inferred from our screen for protein
carbonyls. It is therefore possible that, in addition to intersub-
unit crosslinking, other oxidation-related modifications that
are not revealed by immunoblotting contribute to Ku inacti-
vation. Ku may be particularly susceptible to oxidation, and an
oxidized form of Ku80 containing sulfenic acid was identified
in a screen for proteins with oxidized cysteines in HeLa cells
(Leonard et al., 2009). Attenuated DNA repair resulting from
damage to DNA repair proteins mirrors the situation in cancer-
prone human syndromes in which inactivating mutations in
DNA repair genes confer a predisposition to cancer.
Thiopurines are acknowledged Type II UVA photosensiti-
zers (Hemmens and Moore, 1986), and 1O2 is likely to be the
major oxidizing species generated in cells exposed to the
synergistically lethal combination of 6-TG and UVA (Zhang
et al., 2007). Proteins are particularly susceptible to
inactivation by 1O2 (Davies, 2003). The tremendous
resistance of certain extremophiles to DNA-damaging
treatments has been ascribed to their superior antioxidant
defenses that prevent protein inactivation. Curiously, the
protection does not extend to 1O2, and these organisms are
not abnormally resistant to treatments that generate this form
of ROS (Schafer et al., 1998; Pogoda de la Vega et al., 2005).
Human antioxidant defenses provide good protection against
H2O2, superoxide anion, and hydroxyl radicals—the by-
products of normal aerobic metabolism—but are less effective
against 1O2. It is noteworthy in this regard that H2O2—an
oxidant that significantly increases the burden of oxidized
DNA 6-TG and normal bases but does not generate 1O2—did
not measurably affect NER capability in our experiments. In
addition, neither etoposide nor camptothecin—both acknowl-
edged sources of oxygen-free radical species but not 1O2
(McGowan et al., 1998)—detectably affected NER. As 1O2 is
the major ROS associated with DNA 6-TG/UVA, these
findings serve to highlight the particular danger that this
form of ROS poses to the DNA repair proteome.
Our experiments in cell culture models were designed to
mimic the events occurring in the sun-exposed skin of
patients taking thiopurines. To amplify the effects of UVA,
we used CCRF-CEM cells. Their DNA mismatch repair
defect allows them to accumulate relatively high levels of
DNA 6-TG without UVA–independent toxicity. In most
experiments, 6-TG replaced between 0.1 and 0.5% DNA
guanine. These levels are nontoxic but cause pronounced
UVA sensitization. Importantly, the effects on DNA repair
were independent of cell type, and the combination of
nontoxic levels of 6-TG and low UVA doses inhibited NER
in cells of keratinocyte (HaCaT) and fibroblast (MRC5VA)
origin as well as in CCRF-CEM leukemia cells. NER was
unaffected by extremely toxic doses of IR, H2O2, or
topoisomerase poisons, indicating that the inhibition asso-
ciated with UVA activation of DNA 6-TG did not simply
reflect impending cell death. The inhibition of NER
occurred rapidly after UVA irradiation of DNA 6-TG-
containing cells (see Supplementary Figure S3 online), an
observation that is more consistent with direct effects on
DNA or proteins rather than any delayed cellular effects
related to cell death. The UVA doses (generally 5–
20 kJ m2) that we used to activate DNA 6-TG are low
and probably within the range sustained by cells in the
lower layers of the dermis (Anderson and Parrish, 1981).
Our experimental DNA 6-TG levels are approximately 5- to
10-fold higher than those in the skin of patients taking
azathioprine (O’Donovan et al., 2005). We use cells
containing somewhat higher levels of DNA 6-TG in order
to provoke a measurable response. Indeed, NER is
effectively abolished under our experimental conditions.
We do not suggest that a similar extreme NER inhibition
occurs in patients’ skin. Instead, we envisage a low level of
chronic impairment that, over many years, is likely to
significantly increase the probability of mutation.
The UVA photosensitivity and high frequency of sun-related
cancer in immunosuppressed organ transplant recipients have
been acknowledged for some time (reviewed in Euvrard et al.,
2003), although the contribution of individual immunosup-
pressants has remained undefined. More recently, evidence of a
significant increase in non-melanoma skin cancer in patients
receiving thiopurines for inflammatory bowel disorders (Peyrin-
Biroulet et al., 2011; Setshedi et al., 2012; Ramiscal and
Brewer, 2013) has strengthened the link between skin cancer
and thiopurine treatment. Significantly, the skin cancer risk
in inflammatory bowel disorder patients is somewhat lower
than that in transplant patients, possibly consistent with a more
episodic nature of thiopurine treatment in the former group. In
both cases, the predominance of tumors on sun-exposed skin
provides compelling evidence of the involvement of solar
radiation and is entirely consistent with a role for UVA
photoactivation of DNA 6-TG in carcinogenesis.
NER provides the principal protection against skin cancer
by removing potentially mutagenic UVB–induced DNA
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lesions. Photosensitivity, defined as the induction of erythema,
has a similar wavelength dependency as the formation of the
DNA photoproducts that are NER substrates (McKinlay and
Diffey, 1987). Skin tumors, including those from thiopurine-
treated patients (McGregor et al., 1997; Queille et al., 2007;
Harwood et al., 2008), contain mutations generally regarded
as signatures of UVB–induced lesions that have escaped
removal by NER. Our findings that NER is compromised when
cells containing DNA 6-TG are exposed to UVA suggest a
potential mechanism by which thiopurine treatment, by
prolonging the persistence of premutagenic DNA lesions,
increases both photosensitivity and cancer risk. A preliminary
analysis of the spectrum of mutations in immuno-
suppression-related skin tumors indicated a predominance
of UVB signature mutations at dipyrimidine sites. It did not
reveal a significant burden of mutations that could be
directly related to DNA oxidation (Harwood et al., 2008).
Whole-exome sequencing of skin cancers associated
with azathioprine treatment now offers a way to distinguish
between direct mutagenesis as a consequence of
enhanced DNA oxidation related to 6-TG/UVA and an
indirect effect via NER inhibition and UVB photoproduct
persistence.
MATERIALS AND METHODS
Cells
6-TG-resistant, DNA mismatch repair–defective CCRF-CEM human
leukemia cells, HeLa cells, MRC5VA human fibroblasts, and ung /
and ungþ /þ MEFs were obtained from CR-UK LRI Cell Services (Clare
Hall Laboratories, South Mimms, Herts, UK). Hamster xrs6 cells
were kindly provided by Dr Mark O’Driscoll, University of Sussex,
East Sussex, UK. The cells were treated with 6-TG in growth medium
for 24 or 48 hours. HeLa and xrs6 cells were synchronized by double
thymidine block (Montaner et al., 2007). Cellular DNA 6-TG was
measured as described in the study by Hofbauer et al. (2011).
UVA irradiation
Cells were irradiated in phosphate-buffered saline using a UVH 253
lamp (UV Light Technology, Birmingham, UK) with a maximum
output of 100 mW cm 2. Emission wavelengths ranged from 320 to
400 nm with a maximum of 365 nm.
Oxidized protein labeling and analysis
Carbonyls. Cell extracts were derivatized with Alexa Fluor 647
fluorescent hydroxylamine (Poon et al., 2007), separated by PAGE,
and visualized by Sypro Ruby staining. Derivatized proteins were
detected by 633 nm fluorescence.
Thiols. Oxidized protein thiols were analyzed as described in Baty
et al. (2002). Samples were separated by PAGE and analyzed as for
carbonylation.
Comet assays
NHEJ. Neutral comet assays (Trevigen, Gaithersburg, MD) were
performed according to the manufacturer’s instructions.
DNA uracil. Alkaline comet assays including UNG digestion were
performed as described in the study by Nilsen et al. (2000). All
comets were analyzed using Comet IV software (Perceptive
Instruments, Bury St Edmunds, UK).
DNA repair in vivo
8-OxoG. CCRF-CEM cells were treated with 6-TG/UVA or KBrO3.
DNA was extracted using the DNAzol reagent (Invitrogen, Paisley,
UK), and DNA 8-oxo-2-deoxyguanosine was determined using the
HT 8-oxo-2-deoxyguanosine ELISA kit II (Trevigen).
UVC photoproducts. DNA 6-4 photoproducts and CPDs were
analyzed by ELISA (CosmoBio, Oxford, UK).
DNA repair in vitro
NHEJ. Cell extracts were incubated with XhoI-linearized, end-
radiolabeled pFastBac Dual plasmid (Invitrogen, Paisley, UK). Fol-
lowing proteinase K digestion, reaction products were separated on
0.7% agarose gels.
NER. Dual-incision assays were performed according to the method
of Laine et al. (2006) except that nuclear extracts were used instead of
whole-cell extracts, and the reaction time was increased to
90 minutes.
OGG-1, UNG, and MYH. For OGG-1 and MYH assays, 50-end
labeled 23-mer oligonucleotides (50-CTTAGTCGCXCGTGTCTATG
CTC-30, where X¼ 8-oxoguanine or 50-CTTAGTCGGAUGTGTCTA
TGCTC-30) were 5-end radiolabeled, annealed to the complementary
strand, and incubated for 30 minutes with nuclear extracts supple-
mented with 10 U of recombinant E. coli endonuclease IV (NEB,
Hitchin, UK) and a 10-fold excess of unlabeled perfectly matched
34-mer oligonucleotide duplex of unrelated sequence. The products
were phenol/chloroform extracted, ethanol precipitated, and analyzed
by denaturing PAGE. Control recombinant OGG-1 and UNG
were obtained from NEB and Trevigen, respectively. For MYH assays,
an oligonucleotide complementary to the 8-oxoG strand that placed
A opposite 8-oxoG was 50-end labeled and annealed to the 8-oxoG-
containing oligonucleotide. Incubation and product analysis was the
same as for OGG-1 and UNG except that endonuclease IV was
omitted.
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